<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To investigate the roles of endothelin and nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) in the regulation of cerebral vascular tone under basal conditions and in <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> following <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> in dogs, we used BQ-123 (cyclo(<z:chebi fb="0" ids="29955,32725">-D-Trp</z:chebi><z:chebi fb="0" ids="32469">-D-Asp</z:chebi>-L-Pro<z:chebi fb="0" ids="32858">-D-Val</z:chebi>-L<z:chebi fb="3" ids="30006">-Leu-</z:chebi>) <z:chebi fb="8" ids="26714">sodium salt</z:chebi>), an endothelin <z:chebi fb="209" ids="16000,53460">ETA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi>, a substrate for the formation of NO, and NG-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi>, an NO synthesis inhibitor, and measured the angiographic diameter of the basilar artery in vivo </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> dogs, intracisternal (i.c.) injection of BQ-123 (0.6 mg/kg) produced a 29.4 +/- 6.11% (P &lt; 0.01) increase in the basal diameter 24 h after injection </plain></SENT>
<SENT sid="2" pm="."><plain>NG-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> (0.6 mg/kg i.c.) produced a 19.3 +/- 2.93% (P &lt; 0.05) decrease in the basal diameter 2 h after injection </plain></SENT>
<SENT sid="3" pm="."><plain>This decrease was significantly attenuated by both BQ-123 (0.06-0.6 mg/kg i.c.) and <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (6 mg/kg i.c.), but not by <z:chebi fb="0" ids="15816">D-arginine</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>In the two-<z:mp ids='MP_0001914'>hemorrhage</z:mp> canine model, BQ-123 significantly inhibited the development of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> (36.9 +/- 4.11% decrease on day 5 and 42.0 +/- 4.54% decrease on day 6 in controls vs 21.7 +/- 4.75% decrease (P &lt; 0.05) on day 5 and 20.8 +/- 4.14% decrease (P &lt; 0.05) on day 6 for 0.6 mg/kg i.c.) significantly attenuated the <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> on day 4 from a mg/kg i.c.) </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, in this model, <z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> (6 30.9 +/- 5.78% decrease (before)) to a 12.6 +/- 5.99% decrease (after) </plain></SENT>
<SENT sid="6" pm="."><plain>The immunoreactive endothelin-1 levels in the endothelial layer and the adventitia of the basilar artery were much higher on days 3 and 7 after the injection of autologous blood than on day 0 before blood injection </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that endogenous endothelin and NO both participate in regulating the basal tone of cerebral arteries, and, therefore, the development of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> following <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> may be at least partially attributed to an impairment of the balanced action of endothelin and NO </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, endothelin <z:chebi fb="209" ids="16000,53460">ETA</z:chebi> <z:chebi fb="68" ids="48706">antagonists</z:chebi> or NO products may be useful in the treatment of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> following <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
</text></document>